Report – Analysis of 2019 UK MHRA GMP Inspection Findings
By
Barbara W. Unger
,
Areas examined in this report:
Data from 2019 UK MHRA inspections
Trends from 2015, 2016, 2018, and 2019 inspections
Conclusions drawn from an analysis of drug inspection data
If you have trouble with the form, please contact
events@redica.com
.
Access the white paper
If you have trouble with the form, please contact
events@redica.com
.